Endocrine therapy of HER-2/neu negative metastatic breast cancer - revising the bookshelf

被引：0
|
作者：
Lueftner, D. [1 ]
机构：
[1] Charite Campus Benjamin Franklin, Med Klin Hamatol Onkol & Tumorimmunol MS, Berlin, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：38 / 39
页数：2
相关论文
共 50 条
  • [31] Her-2/neu and Topoisomerase iiα in Breast Cancer
    Tero A.H. Järvinen
    Edison T. Liu
    Breast Cancer Research and Treatment, 2003, 78 : 299 - 311
  • [32] TRASTUZUMAB BEYOND PROGRESSION IN PATIENTS WITH HER-2/NEU POSITIVE METASTATIC BREAST CANCER
    Eralp, Yesim
    JOURNAL OF BREAST HEALTH, 2009, 5 (01): : 3 - 8
  • [33] HER-2/neu in locally advanced breast cancer
    Quevedo Gutierrez, Karla Malinalli
    Landa Fernandez, Ana Maria
    Garcia Barrera, Victor
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 (03): : 108 - 115
  • [34] Trastuzumab and oral vinorelbine (±endocrine therapy) as primary therapy in patients (pts) with HER-2/neu positive breast cancer.
    Torrisi, R.
    Magni, E.
    Dellapasqua, S.
    D'Alessandro, C.
    Veronesi, P.
    Luini, A.
    Minchella, I
    Ghisini, R.
    Nole, F.
    Viale, G.
    Goldhirsch, A.
    Colleoni, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S148 - S148
  • [35] VARIABLE EXPRESSION OF EGFR AND HER-2/NEU IN PRIMARY AND METASTATIC BREAST-CANCER
    LOWER, EE
    HEFFELFINGER, SC
    MILLER, MA
    FENOGLIOPREISER, CM
    CLINICAL RESEARCH, 1994, 42 (03): : A424 - A424
  • [36] Serum HER-2/neu levels in clinical studies with lapatinib in HER-2/neu positive breast cancer
    Maltzman, J.
    Blackwell, K.
    Stein, S.
    Martin, A.
    Westland, R.
    Burstein, H.
    Gomez, H.
    Gartner, N.
    Platek, G.
    Newmiller, M.
    Lipton, A.
    Carney, W. P.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A130 - A130
  • [37] HER-2/neu oncogene amplification in breast cancer
    Depowski, PL
    Brien, TP
    Sheehan, CE
    Muraca, PJ
    Stylos, S
    Johnson, RL
    Ross, JS
    MODERN PATHOLOGY, 1998, 11 (01) : 18A - 18A
  • [38] Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer
    Gonzalez-Angulo, Ana M.
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    ONCOLOGIST, 2006, 11 (08): : 857 - 867
  • [39] Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer
    Reinert, Tomas
    de Paula, Bruno
    Shafaee, Maryam Nemati
    Souza, Pedro Henrique
    Ellis, Matthew J.
    Bines, Jose
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (03)
  • [40] HER-2/NEU ONCOGENE AS A PROGNOSTIC FACTOR IN NODE NEGATIVE BREAST-CANCER
    PATERSON, AHG
    FOURNEY, RM
    DIETRICH, KD
    DANYLUK, J
    JAMIL, N
    LEES, AW
    KRAUSE, B
    MCEWAN, A
    LUKKA, H
    HANSON, J
    MCBLAIN, WH
    WILLAN, B
    SLAMON, DJ
    PATERSON, MC
    BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 109 - 109
12345